Nisa Investment Advisors’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
Nisa Investment Advisors's ANAB Position: Q2 2026 in Review
Nisa Investment Advisors reduced its AnaptysBio (ANAB) stake by 6% in Q2 2026, selling an estimated $2.36K and leaving 610 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1927.
Nisa Investment Advisors first reported a position in ANAB in Q3 2018 and has held it in 31 quarters since. The position peaked at $46.7K in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- Nisa Investment Advisors held 610 shares of AnaptysBio worth $41.2K as of Q2 2026.
- Nisa Investment Advisors sold 39 AnaptysBio shares in Q2 2026, an estimated $2.36K.
- AnaptysBio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1927 holding.
- Nisa Investment Advisors first reported a position in AnaptysBio in Q3 2018 and has held it in 31 quarters since.
- Nisa Investment Advisors's AnaptysBio position peaked at $46.7K in Q4 2025.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.